Scott Rocklage of 5AM Ventures Pioneers Research to Find Appropriate Cures to Generic Diseases

ByTippyGrant

Scott Rocklage of 5AM Ventures Pioneers Research to Find Appropriate Cures to Generic Diseases

Expansion Therapeutics is working hard to raise money for the sole purpose of battling generic disorders in patients. Some of these disorders include dystrophy and myoptonic. Medical reports indicate that these disorders lead to a condition called dystrophy. Donations from well-wishers have been added to the initial contribution of $55.3 million, which, the company added to its donor’s account to battle this disease. The most devastating factor about this disease is that symptoms only manifest when it is at its toxic level. Stakeholders are working towards finding the appropriate cure. Scott Rocklage of 5AM Ventures is one of the dedicated stakeholders.

 

 

 

Stakeholders

 

 

 

To combat this disease, several stakeholders have come forward with various financing proposals. Some of these ventures include Sanofi Ventures, Kleiner Perkins, 5AM Ventures and Alexandria Venture Investments.

 

 

 

RNAs

 

 

 

RNAs are known as molecules that are often transferred from the body cells DNA then converted to proteins. With time, some of the RNA toxins reach the body cells. That is when the condition progresses to DM1. At that moment, the muscles, hormonal system, the heart and respiratory system defy the normal body functioning by becoming defective.

 

 

 

DM1

 

 

 

DM1 can be hereditary. With time, the affected patient passes the gene to the next generation. Although the medical community still has subsequent challenges regarding its treatment, it is evident that there are efforts to create an effective treatment for the disease.

 

 

 

Additional Information

 

 

 

Scott Rocklage is a doctor by profession. He doubles as an entrepreneur and team leader. His experience is an accurate reflection of how good of a leader he has been in the past. Initially, he served as the chairman of Cubist Pharmaceuticals. Around the same period, he worked as a president at Nycomed Salutar. Currently, Rocklage serves as a managing partner at 5AM Ventures. He joined the organization in 2003 and became a partner in 2014.

 

 

 

Overview

 

 

 

In his interview with IdeaMensch, Rocklage confessed that his business encompasses life science-based approaches that contribute to the growth of a healthy community. For him, working at 5AM Ventures has paved the way for better patient treatment especially in medical facilities that he serves as a stakeholder.

 

To learn more, visit http://5amventures.com/team/scott-m-rocklage-phd/.

About the author

TippyGrant administrator

Leave a Reply